233 related articles for article (PubMed ID: 32036457)
21. [Management of retroperitoneal lymphadenectomy in advanced epithelial ovarian cancer].
Jaffré I; Bordes V; Dejode M; Dravet F; Classe JM
Bull Cancer; 2010 Jan; 97(1):65-71. PubMed ID: 19995689
[TBL] [Abstract][Full Text] [Related]
22. Lymph node-positive stage IIIC ovarian cancer: a separate entity?
Berek JS
Int J Gynecol Cancer; 2009 Dec; 19 Suppl 2():S18-20. PubMed ID: 19955908
[TBL] [Abstract][Full Text] [Related]
23. Primary debulking surgery for advanced epithelial ovarian cancer with isolated enlarged para-aortic lymph node by robotic transumbilical single port approach.
Chen Y; Zheng Y; Yang F
Int J Gynecol Cancer; 2023 Dec; 33(12):1976-1977. PubMed ID: 37597853
[No Abstract] [Full Text] [Related]
24. Update on lymphadenectomy in early and advanced ovarian cancer.
Angioli R; Plotti F; Palaia I; Calcagno M; Montera R; Cafà EV; Sereni MI; Panici PB
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):34-9. PubMed ID: 18197003
[TBL] [Abstract][Full Text] [Related]
25. Lymphadenectomy in surgical stage I epithelial ovarian cancer.
Svolgaard O; Lidegaard O; Nielsen ML; Nedergaard L; Mosgaard BJ; Lidang M; Mogensen O; Kock K; Blaakaer J; Staehr E; Andersen ES; Grove A; Høgdall C
Acta Obstet Gynecol Scand; 2014 Mar; 93(3):256-60. PubMed ID: 24447203
[TBL] [Abstract][Full Text] [Related]
26. Salvage lymphadenectomy in recurrent ovarian cancer patients: Analysis of clinical outcome and BRCA1/2 gene mutational status.
Gallotta V; Bruno M; Conte C; Giudice MT; Davià F; Moro F; Zannoni GF; Fagotti A; De Bonis M; Capoluongo E; Scambia G; Ferrandina G
Eur J Surg Oncol; 2020 Jul; 46(7):1327-1333. PubMed ID: 32085925
[TBL] [Abstract][Full Text] [Related]
27. Role of cardiophrenic lymph node removal in advanced ovarian cancer.
Boria F; Chiva L
Int J Gynecol Cancer; 2021 Feb; 31(2):307. PubMed ID: 33273019
[No Abstract] [Full Text] [Related]
28. Maximum effort in the management of ovarian cancer, including pelvic and para-aortic lymphadenectomy.
Allen DG; Planner RS; Grant PT
Aust N Z J Obstet Gynaecol; 1992 Feb; 32(1):50-3. PubMed ID: 1586336
[TBL] [Abstract][Full Text] [Related]
29. Single-Site Robot-Assisted Laparoscopic Staging Surgery for Presumed Clinically Early-Stage Ovarian Cancer.
Yoo JG; Kim WJ; Lee KH
J Minim Invasive Gynecol; 2018; 25(3):380-381. PubMed ID: 28911827
[TBL] [Abstract][Full Text] [Related]
30. Impact of lymphadenectomy on survival after recurrence in patients with advanced ovarian cancer without suspected lymph node metastasis.
Paik ES; Shim M; Choi HJ; Lee YY; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
Gynecol Oncol; 2016 Nov; 143(2):252-257. PubMed ID: 27567053
[TBL] [Abstract][Full Text] [Related]
31. Using a new diagnostic tool to predict lymph node metastasis in advanced epithelial ovarian cancer leads to simple lymphadenectomy decision rules: A multicentre study from the FRANCOGYN group.
Mimoun C; Paoletti X; Gaillard T; Crestani A; Benifla JL; Mezzadri M; Bendifallah S; Touboul C; Bricou A; Dabi Y; Canlorbe G; Kerbage Y; Lavoué V; Ouldamer L; Lecointre L; Coutant C; Fauconnier A; Rouzier R; Huchon C
PLoS One; 2021; 16(10):e0258783. PubMed ID: 34665839
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of epithelian ovarian cancer should be followed by lymphadenectomy--a systematic review].
Dybro A; Blaakær J
Ugeskr Laeger; 2012 Mar; 174(13):865-70. PubMed ID: 22456174
[TBL] [Abstract][Full Text] [Related]
33. The relationship between retroperitoneal lymphadenectomy and survival in advanced ovarian cancer patients.
Fang C; Zhang Y; Zhao L; Chen X; Xia L; Zhang P
BMC Cancer; 2020 Jul; 20(1):654. PubMed ID: 32660444
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and prognostic impact of lymphadenectomy and lymph node metastasis in clinically early-stage ovarian clear cell carcinoma.
Mahdi H; Moslemi-Kebria M; Levinson KL; Gojayev A; Lockhart D; Ali-Fehmi R; Munkarah AR
Int J Gynecol Cancer; 2013 Sep; 23(7):1226-30. PubMed ID: 23736258
[TBL] [Abstract][Full Text] [Related]
35. Sentinel-node biopsy in early stage ovarian cancer: a prospective multicentre study (SELLY).
Scambia G; Nero C; Uccella S; Vizza E; Ghezzi F; Cosentino F; Chiantera V; Fagotti A
Int J Gynecol Cancer; 2019 Nov; 29(9):1437-1439. PubMed ID: 31601646
[TBL] [Abstract][Full Text] [Related]
36. [The clinical significance of retroperitoneal lymph node metastasis and lymphadenectomy on 3-year survival in ovarian carcinoma].
Takahashi Y; Akiyama M; Hirose M; Yamamoto Y; Tenzaki T; Ishiguro T; Noda Y
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Oct; 45(10):1095-100. PubMed ID: 8245587
[TBL] [Abstract][Full Text] [Related]
37. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Surgical Management of Advanced Stages of Borderline Ovarian Tumours].
Raimond E; Bourdel N
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):304-313. PubMed ID: 32004785
[TBL] [Abstract][Full Text] [Related]
38. Mucinous borderline ovarian tumor versus invasive well-differentiated mucinous ovarian cancer: Difference in characteristics and outcomes.
Matsuo K; Machida H; Mandelbaum RS; Grubbs BH; Roman LD; Sood AK; Gershenson DM
Gynecol Oncol; 2019 May; 153(2):230-237. PubMed ID: 30797590
[TBL] [Abstract][Full Text] [Related]
39. Real-world study of lymphadenectomy in patients with advanced epithelial ovarian cancer.
Yin Z; Wang M
J Obstet Gynaecol Res; 2024 Apr; 50(4):663-670. PubMed ID: 38332458
[TBL] [Abstract][Full Text] [Related]
40. [Validity of complete paraaortic and pelvic lymphadenectomy in apparent stage I (T1) epithelial ovarian carcinoma].
Shimizu Y
Nihon Rinsho; 2004 Oct; 62 Suppl 10():570-7. PubMed ID: 15535310
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
